Free Trading + Demat + Mutual Fund + 0 AMC

Free Trading + Demat + Mutual Fund + 0 AMC
Click the image to open account

Sunday, October 13, 2019

AUROBINDO PHARMA UPDATE

Further to the clarification sought by you on Unit-7 facility inspection by USFDA and issue of Form 483 with 7 observations, we inform that these observations have no impact on the existing business with respect to the operations and revenues. 

Hence, no disclosure was made earlier. The Company will be sending responses to the observations within the stipulated time to the regulatory authority.